Our Chief Scientific Officer and Deputy CEO, Sofia Corte-Real, will act as both the chair and a speaker at the upcoming 6th Annual Bacteriophage Summit scheduled for February 27 to 29 in Boston! Sofia’s presentation will focus on the ongoing Phase 2b Clinical Trial of TP-102, titled “Management of Diabetic Foot Infections Using Phage Products: Unveiling TP-102 Phase 2b Study.” Join her as she unveils the innovative nature of TP-102 bacteriophage cocktail.
Sofia Côrte-Real on behalf of Technophage at the 6th Annual Bacteriophage Summit
